Cite
Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis study.
MLA
Jakimovski, Dejan, et al. “Therapy Effect on AI-Derived Thalamic Atrophy Using Clinical Routine MRI Protocol: A Longitudinal, Multi-Center, Propensity-Matched Multiple Sclerosis Study.” Multiple Sclerosis and Related Disorders, vol. 74, June 2023, p. 104708. EBSCOhost, https://doi.org/10.1016/j.msard.2023.104708.
APA
Jakimovski, D., Silva, D., Niels Bergsland, Dwyer, M. G., Weinstock-Guttman, B., Benedict, R. H., Riolo, J., & Zivadinov, R. (2023). Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis study. Multiple Sclerosis and Related Disorders, 74, 104708. https://doi.org/10.1016/j.msard.2023.104708
Chicago
Jakimovski, Dejan, Diego Silva, Niels Bergsland, Michael G Dwyer, Bianca Weinstock-Guttman, Ralph Hb Benedict, Jon Riolo, and Robert Zivadinov. 2023. “Therapy Effect on AI-Derived Thalamic Atrophy Using Clinical Routine MRI Protocol: A Longitudinal, Multi-Center, Propensity-Matched Multiple Sclerosis Study.” Multiple Sclerosis and Related Disorders 74 (June): 104708. doi:10.1016/j.msard.2023.104708.